Treatment Outcome and Chemoresistance-Related Factors of Low-Risk Gestational Trophoblastic Neoplasia: Results From a Tertiary Care Center in Saudi Arabia
Patients with FIGO scores of 5-6 and high β-hCG levels had increased resistance to first-line therapy. β-hCG was the strongest independent predictor. These findings highlight the need to reassess treatment strategies for this subgroup.
Authors
- Abdulrahman Alghabban (ORCID: https://orcid.org/0000-0003-3009-1014)
- Mohamed Aseafan (ORCID: https://orcid.org/0000-0001-9993-9664)
- Alanoud Alhumaidi
- Shouki Bazarbashi (ORCID: https://orcid.org/0000-0002-8913-8158)
- Nermin Fahmy
- Irfan Maghfoor (ORCID: https://orcid.org/0000-0002-5748-5817)
- Ahmed Gad (ORCID: https://orcid.org/0000-0003-3179-9989)
- Rahaf Ahmed Ali Alshihri
- Inaam Ahmed Ibrahim (ORCID: https://orcid.org/0009-0009-7727-2091)
- Hamed Alhusseini (ORCID: https://orcid.org/0000-0003-4976-2180)
- Bader Alshamsan (ORCID: https://orcid.org/0000-0003-2462-0581)
- Zainab Aziz Al-Sahwan
Institutions
- Ain Shams University (EG)
- Suez Canal University (EG)
- Alfaisal University (SA)
- Qassim University (SA)
- King Faisal Specialist Hospital & Research Centre (SA)
- Security Forces Hospital (SA)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1200/go-25-00172
- Primary Topic
- Gestational Trophoblastic Disease Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00